Heart failure (HF) is a complex disease in which cardiomyocyte injury leads to a cascade of
inflammatory and fibrosis pathway activation, thereby causing decrease in cardiac function …

Motivation Heart failure (HF) is a cardiovascular disease with a high incidence around the
world. Accumulating studies have focused on the identification of biomarkers for HF …

We investigated the ability of copeptin level to predict adverse outcome in pediatric heart
failure (HF) and correlated copeptin level with various clinical and echocardiographic data …

Cardiac myosin binding protein-C (cMyBP-C) is a heart muscle-specific thick filament
protein. Elevated level of serum cMyBP-C is an indicator of early myocardial infarction (MI) …

(1) Background: Given its high cardiac specificity and its capacity to directly assess the
cardiac function, cardiac myosin-binding protein (MyBP-C) is a promising biomarker in …

Aims Cardiac myosin‐binding protein C (cMyC) seems to be even more sensitive in the
quantification of cardiomyocyte injury vs. high‐sensitivity cardiac troponin, and may …

Background: We aimed to evaluate serum soluble suppression of tumorigenicity-2 in
children with congestive heart failure, to assess the diagnostic and prognostic values of …

We investigated the prognostic value of cardiac myosin-binding protein C (cMyC), a novel
cardiospecific marker, both independently and in combination with N-terminal pro-B-type …

心力衰竭是一组复杂的临床综合征. 儿童心力衰竭(pediatric heart failure, PHF)
具有较高的病死率. 早期诊断对于PHF 的治疗和管理至关重要. 在临床实践中 …

Apelin is an endogenous inotrope that decreased in heart failure (HF). We aimed to evaluate
the prognostic value of its level in children with HF due to congenital heart disease (CHD) …